160 related articles for article (PubMed ID: 34888227)
1. Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer.
Deng L; Wang D; Chen S; Hu W; Zhang R
Front Oncol; 2021; 11():653782. PubMed ID: 34888227
[TBL] [Abstract][Full Text] [Related]
2. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer.
Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W
J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423
[TBL] [Abstract][Full Text] [Related]
3. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
[TBL] [Abstract][Full Text] [Related]
4. Epiphycan is specifically expressed in cochlear supporting cells and is necessary for normal hearing.
Hanada Y; Nakamura Y; Ishida Y; Takimoto Y; Taniguchi M; Ozono Y; Koyama Y; Morihana T; Imai T; Ota Y; Sato T; Inohara H; Shimada S
Biochem Biophys Res Commun; 2017 Oct; 492(3):379-385. PubMed ID: 28864419
[TBL] [Abstract][Full Text] [Related]
5. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway.
Ma N; Zhao Y
Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818
[TBL] [Abstract][Full Text] [Related]
6. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract][Full Text] [Related]
7. KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer.
Li Z; Huang L; Wei L; Zhang B; Zhong S; Ou Y; Wen C; Huang S
Onco Targets Ther; 2020; 13():10323-10333. PubMed ID: 33116612
[TBL] [Abstract][Full Text] [Related]
8. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer.
Zheng YZ; Liang L
Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
10. OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K/AKT/mTOR pathway.
Xie W; Yu J; Yin Y; Zhang X; Zheng X; Wang X
Front Oncol; 2022; 12():876257. PubMed ID: 36033461
[TBL] [Abstract][Full Text] [Related]
11. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism].
Feng TF; Yao DM; Zheng R; Jiang DS; Zhang LL; Xing Q; Li L
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):139-146. PubMed ID: 35184457
[No Abstract] [Full Text] [Related]
12. Endoplasmic reticulum stress regulates proliferation, migration and invasion of human ovarian cancer SKOV3 cells through PI3K/AKT/mTOR signaling pathway.
Yang N; Qu YJ; Cheng Y; Liang T; Zhang MN; Zhang D; Dong LN; Wang XW; Zhang GM
Cancer Biomark; 2017 Jul; 19(3):263-269. PubMed ID: 28453460
[TBL] [Abstract][Full Text] [Related]
13. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
14. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway.
Zhu J; Hu H; Wang J; Yang Y; Yi P
Cell Physiol Biochem; 2018; 49(2):696-705. PubMed ID: 30165366
[TBL] [Abstract][Full Text] [Related]
15. KDF1 Promoted Proliferation and Metastasis of Epithelial Ovarian Cancer
Zhu C; Liu Y; Tong R; Guan J
Front Genet; 2022; 13():808100. PubMed ID: 35281796
[No Abstract] [Full Text] [Related]
16. [The role and mechanism of human trophoblastic cell surface antigen 2 in the invasion and metastasis of ovarian cancer].
Liu MB; Shi XF; Liu K; Song WY; Wang L; Wu HY; Wu GY
Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):299-305. PubMed ID: 33752309
[No Abstract] [Full Text] [Related]
17. CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway.
Zhang LQ; Yang HQ; Yang SQ; Wang Y; Chen XJ; Lu HS; Zhao LP
Technol Cancer Res Treat; 2019 Jan; 18():1533033819874773. PubMed ID: 31537175
[TBL] [Abstract][Full Text] [Related]
18. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
[TBL] [Abstract][Full Text] [Related]
19. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ
Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441
[No Abstract] [Full Text] [Related]
20. An evaluation of OPTC and EPYC as candidate genes for high myopia.
Wang P; Li S; Xiao X; Guo X; Zhang Q
Mol Vis; 2009 Oct; 15():2045-9. PubMed ID: 19844586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]